SCHEMBL7597067

SCHEMBL7597067

CN(C1CCNCC1)[C@H]1CCCc2ccccc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.49
XBP1 P17861 1/20 0.49
HTT P42858 1/20 0.49
RAB9A P51151 1/20 0.47
CYP2D6 P10635 2/20 0.46
ADRA2A P08913 2/20 0.46
ADRA1A P35348 2/20 0.46
HTR1A P08908 1/20 0.46
OPRM1 P35372 1/20 0.46
MEN1 O00255 1/20 0.45
BLM P54132 1/20 0.45
KMT2A Q03164 1/20 0.45
TAAR1 Q96RJ0 1/20 0.45
MAOA P21397 1/20 0.40
MAOB P27338 1/20 0.40
ADRA1D P25100 1/20 0.40
ADRA1B P35368 1/20 0.40
IDO1 P14902 1/20 0.40
HTR2A P28223 1/20 0.40
HTR2C P28335 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7597072 1.00 ALDH1A1 (0.49) ALDH1A1XBP1HTTRAB9ACYP2D6
SCHEMBL7510531 0.82 ALDH1A1 (0.49) ALDH1A1XBP1HTTRAB9AMEN1
SCHEMBL9054763 0.80 HTR2C (0.42) ALDH1A1CYP2D6ADRA2AADRA1AHTR1A
SCHEMBL12182299 0.77 CHRNB2 (0.60) ALDH1A1XBP1HTTRAB9AMAOA
SCHEMBL3053926 0.77 CHRNB2 (0.60) ALDH1A1XBP1HTTRAB9AMAOA
SCHEMBL12182270 0.77 CHRNB2 (0.60) ALDH1A1XBP1HTTRAB9AMAOA
SCHEMBL7517086 0.75 HTR2C (0.38) HTR1AMEN1KMT2AHTR2AHTR2C
SCHEMBL7517081 0.75 HTR2C (0.38) HTR1AMEN1KMT2AHTR2AHTR2C
SCHEMBL7117305 0.73 MAOA (0.60) ALDH1A1XBP1HTTRAB9AMAOA
SCHEMBL7597118 0.73 ALDH1A1 (0.52) ALDH1A1XBP1HTTRAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1198463-A2 COMPOUNDS FOR USE IN TREATMENT OF NEUROLOGICAL DISORDERS AstraZeneca UK Limited (GB) 2002-04-24 EP disclosed
WO-2000078751-A2 COMPOUNDS FOR USE IN TREATMENT OF NEUROLOGICAL DISORDERS ASTRAZENECA UK LIMITED (GB) 2000-12-28 WO disclosed